{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:54:35Z","timestamp":1790884475785,"version":"4.1.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Jilin Provincial Science and Technology Project","award":["2019SCZ007"],"award-info":[{"award-number":["2019SCZ007"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide. The mechanisms underlying this trend are not yet fully understood. This study aimed to examine the potential role of genetically predicted immunophenotypes in the development of CRC. A two-sample bidirectional Mendelian randomization study was conducted to explore the relationship between 731 genetically predicted immune cells and CRC. Furthermore, a two-step Mendelian randomization approach was employed to assess the possible mediating effect of immune cells on CRC. The inverse-variance weighted method identified 5 immunophenotypes as significantly inversely associated with CRC risk: the odds ratios for CRC risk associated with activated CD4 regulatory T cells (%CD4 regulatory T cells), CD25++ CD45RA- CD4 nonregulatory T cells (%CD4\u2005+\u2005T cells), CD25++ CD45RA- CD4 nonregulatory T cells (%T cells), CD25++ CD8\u2005+\u2005T cells (%T cells), and CD64\u2005+\u2005CD16\u2005+\u2005monocytes were 0.925 (95% CI\u2005=\u20050.874\u20130.978,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20056.516\u2005\u00d7\u200510\n                      <jats:sup>\u22123<\/jats:sup>\n                      ), 0.935 (95% CI\u2005=\u20050.878\u20130.995,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.035), 0.936 (95% CI\u2005=\u20050.889\u20130.985,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.011), 0.863 (95% CI\u2005=\u20050.786\u20130.948,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20052.142\u2005\u00d7\u200510\n                      <jats:sup>\u22123<\/jats:sup>\n                      ), and 0.636 (95% CI\u2005=\u20050.519\u20130.778,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20051.18\u2005\u00d7\u200510\n                      <jats:sup>\u22125<\/jats:sup>\n                      ), respectively. The mediation analysis indicated that the absolute count of CD25++ CD8\u2005+\u2005T cells led to a 33.9% decrease in the risk associated with the percentage of activated CD4 regulatory T cells within CD4 regulatory T cells and CRC. Our analysis revealed that 5 immunophenotypes may be risk factors for CRC. Since other complementary methods have yielded inconsistent results, however, further investigation is necessary.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049769","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:02:23Z","timestamp":1783720943000},"page":"e49769","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["To unveil the causal relationship between immunophenotypes and colorectal cancer using two-sample bidirectional Mendelian randomization and mediation analyses"],"prefix":"10.1097","volume":"105","author":[{"given":"Yi","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Colorectal Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyuan","family":"Fei","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Colorectal Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuedong","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Colorectal Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5942-1542","authenticated-orcid":false,"given":"Suyan","family":"Tian","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, The First Hospital of Jilin University, Changchun, Jilin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261001","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer.","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"},{"key":"R2-20261001","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.semcancer.2021.04.007","article-title":"Integrated approaches for precision oncology in colorectal cancer: the more you know, the better.","volume":"84","author":"Andrei","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"R3-20261001","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3390\/nu11010164","article-title":"Colorectal cancer and nutrition.","volume":"11","author":"Thanikachalam","year":"2019","journal-title":"Nutrients"},{"key":"R4-20261001","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1470-2045(17)30202-4","article-title":"Colorectal cancer: a disease of the young?","volume":"18","year":"2017","journal-title":"Lancet Oncol"},{"key":"R5-20261001","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ijc.34691","article-title":"Circulating white blood cell traits and colorectal cancer risk: a Mendelian randomisation study.","volume":"154","author":"Constantinescu","year":"2024","journal-title":"Int J Cancer"},{"key":"R6-20261001","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cell.2020.03.001","article-title":"The emerging landscape of immune cell therapies.","volume":"181","author":"Weber","year":"2020","journal-title":"Cell"},{"key":"R7-20261001","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.immuni.2022.12.008","article-title":"Microenvironment-driven metabolic adaptations guiding CD8+ T cell anti-tumor immunity.","volume":"56","author":"Park","year":"2023","journal-title":"Immunity"},{"key":"R8-20261001","doi-asserted-by":"crossref","first-page":"e001369","DOI":"10.1136\/jitc-2020-001369","article-title":"Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity.","volume":"8","author":"Efimova","year":"2020","journal-title":"J ImmunoTher Cancer"},{"key":"R9-20261001","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1016\/j.cell.2021.08.003","article-title":"Spatially organized multicellular immune hubs in human colorectal cancer.","volume":"184","author":"Pelka","year":"2021","journal-title":"Cell"},{"key":"R10-20261001","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3389\/fimmu.2020.00369","article-title":"Relationships between immune landscapes, genetic subtypes and responses to immunotherapy in colorectal cancer.","volume":"11","author":"Picard","year":"2020","journal-title":"Front Immunol"},{"key":"R11-20261001","doi-asserted-by":"crossref","first-page":"778329","DOI":"10.3389\/fimmu.2021.778329","article-title":"Colorectal cancer-associated immune exhaustion involves T and B lymphocytes and conventional NK cells and correlates with a shorter overall survival.","volume":"12","author":"Sorrentino","year":"2021","journal-title":"Front Immunol"},{"key":"R12-20261001","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","article-title":"Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer.","volume":"173","author":"Hoadley","year":"2018","journal-title":"Cell"},{"key":"R13-20261001","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer.","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"R14-20261001","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies.","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R15-20261001","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization.","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"R16-20261001","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy.","volume":"52","author":"Orr\u00f9","year":"2020","journal-title":"Nat Genet"},{"key":"R17-20261001","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","article-title":"A cross-population atlas of genetic associations for 220 human phenotypes.","volume":"53","author":"Sakaue","year":"2021","journal-title":"Nat Genet"},{"key":"R18-20261001","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomization studies: a guide, glossary, and checklist for clinicians.","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"R19-20261001","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/0962280210394459","article-title":"Using multiple genetic variants as instrumental variables for modifiable risk factors.","volume":"21","author":"Palmer","year":"2012","journal-title":"Stat Methods Med Res"},{"key":"R20-20261001","doi-asserted-by":"crossref","first-page":"e1003288","DOI":"10.1371\/journal.pmed.1003288","article-title":"Genetics of height and risk of atrial fibrillation: a Mendelian randomization study.","volume":"17","author":"Levin","year":"2020","journal-title":"PLoS Med"},{"key":"R21-20261001","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/ije\/dyz200","article-title":"Education protects against coronary heart disease and stroke independently of cognitive function: evidence from Mendelian randomization.","volume":"48","author":"Gill","year":"2019","journal-title":"Int J Epidemiol"},{"key":"R22-20261001","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","article-title":"Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors.","volume":"30","author":"Burgess","year":"2015","journal-title":"Eur J Epidemiol"},{"key":"R23-20261001","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R24-20261001","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R25-20261001","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption.","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R26-20261001","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data.","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"R27-20261001","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","article-title":"Mendelian randomisation for mediation analysis: current methods and challenges for implementation.","volume":"36","author":"Carter","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"R28-20261001","doi-asserted-by":"crossref","first-page":"1031216","DOI":"10.3389\/fimmu.2022.1031216","article-title":"Monocyte response after colorectal surgery: a prospective cohort study.","volume":"13","author":"Edomskis","year":"2022","journal-title":"Front Immunol"},{"key":"R29-20261001","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12026-012-8297-3","article-title":"The three human monocyte subsets: implications for health and disease.","volume":"53","author":"Wong","year":"2012","journal-title":"Immunol Res"},{"key":"R30-20261001","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.immuni.2012.12.001","article-title":"Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis.","volume":"38","author":"Yona","year":"2013","journal-title":"Immunity"},{"key":"R31-20261001","doi-asserted-by":"crossref","first-page":"151958","DOI":"10.1016\/j.imbio.2020.151958","article-title":"Epigenetics in non-classical monocytes support their pro-inflammatory gene expression.","volume":"225","author":"Zhang","year":"2020","journal-title":"Immunobiology"},{"key":"R32-20261001","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.3390\/cancers12092513","article-title":"Blood monocyte subsets with activation markers in relation with macrophages in non-small cell lung cancer.","volume":"12","author":"Kwiecien","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R33-20261001","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2249.2011.04321.x","article-title":"CD16\u00fe monocytes in breast cancer patients: expanded by monocyte chemoattractant protein-1 and may be useful for early diagnosis.","volume":"164","author":"Feng","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"R34-20261001","doi-asserted-by":"crossref","first-page":"e44450","DOI":"10.1371\/journal.pone.0044450","article-title":"Intermediate monocytes but not TIE2-expressing monocytes are a sensitive diagnostic indicator for colorectal cancer.","volume":"7","author":"Schauer","year":"2012","journal-title":"PLoS One"},{"key":"R35-20261001","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nm.4466","article-title":"High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy.","volume":"24","author":"Krieg","year":"2018","journal-title":"Nat Med"},{"key":"R36-20261001","doi-asserted-by":"crossref","first-page":"108677","DOI":"10.1016\/j.clim.2021.108677","article-title":"Immunological features of circulating monocyte subsets in patients with squamous cell carcinoma of the head and neck.","volume":"225","author":"Sakakura","year":"2021","journal-title":"Clin Immunol"},{"key":"R37-20261001","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1080\/10428194.2021.1885659","article-title":"Expression levels of HLA-DR in acute myeloid leukemia: implications for antigenicity and clinical outcome.","volume":"62","author":"Roerden","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"R38-20261001","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease.","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"R39-20261001","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat Med"},{"key":"R40-20261001","doi-asserted-by":"crossref","first-page":"18538","DOI":"10.1073\/pnas.0509182102","article-title":"Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.","volume":"102","author":"Sato","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"R41-20261001","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1158\/1078-0432.CCR-06-0369","article-title":"Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.","volume":"12","author":"Hiraoka","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R42-20261001","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1158\/1078-0432.CCR-06-2363","article-title":"FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis.","volume":"13","author":"Kobayashi","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R43-20261001","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1200\/JCO.2006.09.4565","article-title":"Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.","volume":"25","author":"Gao","year":"2007","journal-title":"J Clin Oncol"},{"key":"R44-20261001","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1200\/JCO.2008.18.7229","article-title":"Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.","volume":"27","author":"Salama","year":"2009","journal-title":"J Clin Oncol"},{"key":"R45-20261001","doi-asserted-by":"crossref","first-page":"e006611","DOI":"10.1136\/jitc-2022-006611","article-title":"Robust IL-2-dependent antitumor immunotherapy requires targeting the high-affinity IL-2R on tumor-specific CD8+ T cells.","volume":"11","author":"LaPorte","year":"2023","journal-title":"J ImmunoTher Cancer"},{"key":"R46-20261001","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/s43018-023-00612-0","article-title":"IL-2R\u03b1-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells.","volume":"4","author":"Wu","year":"2023","journal-title":"Nat Cancer"},{"key":"R47-20261001","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1186\/s12888-023-05081-4","article-title":"Causal role of immune cells in schizophrenia: Mendelian randomization (MR) study.","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Psychiatry"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:00:59Z","timestamp":1790881259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":47,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049769","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"2024-04-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}